Innovative approaches in unmet clinical needs for maximum health care impact
| |
go to QR-CODE |
|
INNOVATIVE APPROACHES IN UNMET CLINICAL NEEDS
September 22 |
||||||
| Co-organized with: |
||||||
    |
||||||
|
WORKSHOP COMMITTEE |
||||||
|
In this day, different actors (academia, industry, regulatory) will discuss and describe the development of innovative and enabling technologies for facing unmet clinical needs, varying from diagnosis to therapeutic aims. In line with Horizon Europe pipelines, pathological focuses will be devoted on cancer, brain related diseases, cardiovascular pathologies. A comprehensive overview of the recent and established innovation in health technologies will be highlighted with a special focus on several aspects strongly impacting on the success of innovation approaches and its application into clinical setting and shown by different sides of view, from design, to materials, characterization, production and scale up, ending to successful stories of yet approved and on market technologies. |
||||||
| September 22 |
||||||
| 09:00 - 10:30 Innovative approaches in UNMET clinical needs for maximum health care impact - Medical Needs WS.II.1 - TT.I.D |
||||||
| Co-organized with Don Gnocchi Foundation, University of Modena and Reggio Emilia, University of Catanzaro and Sapienza University of Rome Chairs: Maria CARAFA, Sapienza University of Rome & Marzia BEDONI, Don Gnocchi Foundation |
||||||
| WS.II.1.1 TT.I.D.1 |
Lorena PASSONI - CV Humanitas Research Hospital Delivering Drug-Loaded Liposomes to Glioblastoma Stem Cells |
 |
 |
|||
| WS.II.1.2 TT.I.D.2 |
Emmanuel GARCION - CV University of Angers, France Design & Application of Innovative Locoregional Treatments in Glioblastoma: Vectorization versus interventionnal tumor traps |
 |
 |
|||
| WS.II.1.3 TT.I.D.3 |
Deborah QUAGLIO - CV Sapienza University of Rome Cell metabolomics: a strategy to study crucial pathways in glioma development |
|
 |
|||
| WS.II.1.4 TT.I.D.4 |
Alessia SARICA - CV University Magna Graecia of Catanzaro Unveiling the Brain and its disorders through Artificial Intelligence |
|
 |
|||
| 11:30 - 13:00 Innovative approaches in UNMET clinical needs for maximum health care impact - Innovation in Academia WS.II.2 - TT.II.D |
||||||
| Co-organized with Don Gnocchi Foundation, University of Modena and Reggio Emilia, University of Catanzaro and Sapienza University of Rome Chairs: Furio GRAMATICA - CV, Don Gnocchi Foundation & Giovanni TOSI - CV, University of Modena and Reggio Emilia |
||||||
| WS.II.2.1 TT.II.D.1 |
Raymond SCHIFFELERS UTRECHT University, The Netherlands & European Technology Platform for Nanomedicine, EU Synthetic or natural lipid nanoparticles for RNA delivery |
 |
 |
|||
| WS.II.2.2 TT.II.D.2 |
Jason DUSKEY - CV University of Modena & Reggio Emilia Improved GBM Targeting: Nanomedicines approaches from conception to testing |
|
 |
|||
| WS.II.2.3 TT.II.D.3 |
Carlo Augusto BORTOLOTTI - CV University of Modena & Reggio Emilia Nanoinnovation in biosensoring: Label-free Organic Biosensors for Diagnostics |
|
 |
|||
| WS.II.2.4 TT.II.D.4 |
Michele DI LAURO - CV IIT Organic Neuroelectronics: a cross-fertilisation story |
|
 |
|||
| WS.II.2.5 TT.II.D.5 |
Amel DJOUDI - CV University of Angers, France Development of innovative nanocomposite hydrogels for the treatment of Glioblastoma Multiforme |
|
 |
|||
| 14:00 - 15:30 Innovative approaches in UNMET clinical needs for maximum health care impact - Translational aspects WS.II.3 - TT.III.D |
||||||
| Co-organized with Don Gnocchi Foundation, University of Modena and Reggio Emilia, University of Catanzaro and Sapienza University of Rome Chairs: Marzia BEDONI, Don Gnocchi Foundation & Giovanni TOSI - CV, University of Modena and Reggio Emilia |
||||||
| WS.II.3.1 TT.III.D.1 |
Furio GRAMATICA - CV Don Gnocchi Foundation Crosstech innovation in Horizon Europe |
|
 |
|||
| WS.II.3.2 TT.III.D.2 |
Dora MEHN - CV European Commission, Directorate General Joint Research Centre, Directorate F – Health, Consumers and Reference Materials, Consumer Products Safety (EU) Advanced methods for sizing nanomedicine materials |
|
 |
|||
| WS.II.3.3 TT.III.D.3 |
Fanny CAPUTO - CV Sintef, Norway Measuring physical properties of liposomes and of lipid-based nanoparticles for RNA delivery: from method development to standardization |
|
 |
|||
| WS.II.3.4 TT.III.D.4 |
Michele DE LUCA - CV University of Modena and Reggio Emilia & Holostem Combined cell and gene therapy for epidermolysis bullosa |
|
 |
|||
| WS.II.3.5 TT.III.D.5 |
Sabrina PRICI University of Trieste & COST Action Nano2Clinic Cancer nanomedicine from the bench to the bedside |
|
 |
|||
| WS.II.3.6 TT.III.D.6 |
Maria DE LA FUENTE - CV Oncomet, Spain DIVERSA, Delivery Innovation for VERsatile Solutions in Advanced Therapeutics |
|
 |
|||
 Back to Overview |
||
